Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes
Sharon L. Mulvagh(Dalhousie University), Mariano I. Chahin(Centre for Advanced Study), Rosario Arechavaleta(Centre for Advanced Study), Francis Chun Chung Chow(Centre for Advanced Study), Žaklina Davicevic-Elez(Novo Nordisk (Denmark)), Robinson Sánchez García(Centre for Advanced Study), Monika Kellerer(Centre for Advanced Study), Federico Pérez Manghi(Centre for Advanced Study), Ole Kleist Jeppesen(Novo Nordisk (Denmark)), Borys Mankovsky(D.F. Chebotarev Institute of Gerontology), Chaicharn Deerochanawong(Rajavithi Hospital), Daniel Piskorz(Centre for Advanced Study), Kim A. Connelly(St. Michael's Hospital), P Schelde(Centre for Advanced Study), Alberto Lorenzatti(Brigham and Women's Hospital), José M Pozzi(Centre for Advanced Study), Virginia Esther Visco(Centre for Advanced Study), Aslam Amod(Centre for Advanced Study), Neil R Poulter(Imperial College London), Shih‐Te Tu, Cyrus Desouza(Omaha VA Medical Center), Matthew A. Cavender, Scott S. Emerson(Cleveland Clinic Lerner College of Medicine), Li Li Ji(University of Wisconsin–Madison), Boris Mankovsky(D.F. Chebotarev Institute of Gerontology), Aytekin Oğuz(Centre for Advanced Study), Kabirdev Mandavya(Novo Nordisk (India)), J Deanfield(University College London), Lucrecia Nardone(Centre for Advanced Study), Kun Ho Yoon(Centre for Advanced Study), Hirotaka Watada(Centre for Advanced Study), José Francisco(Centre for Advanced Study), SOUL Study Group, Mads D. M. Engelmann(Novo Nordisk (Denmark)), Pardeep S. Jhund(Centre for Advanced Study), Johannes F. E. Mann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Nikolaus Marx(Westfälische Hochschule), Andreas L. Birkenfeld(Centre for Advanced Study), Juan J. Gorgojo-Martinez(Hospital Universitario Fundación Alcorcón), G. Kees Hovingh(Novo Nordisk (Denmark)), John B. Buse(University of North Carolina at Chapel Hill), Rodica Pop-Busui(Oregon Health & Science University), Carolyn S. P. Lam(Centre for Advanced Study), Darren K. McGuire(Parkland Health & Hospital System), Martin Haluzik(Centre for Advanced Study), S. E. Inzucchi(Yale University), Stephen C. Bain(Swansea University), Søren Gregersen(Steno Diabetes Centers)
Cited by 4
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k